Newbridge Financial Services Group, Inc. Ardelyx, Inc. Transaction History

Newbridge Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 11, 2024	SELL	$5.89 - $9.31 $4,417 - $6,982	-750 Reduced 8.57%	8,000 $59,000
Q1 2024 Apr 24, 2024	BUY	$6.05 - $9.74 $52,937 - $85,225	8,750 New	8,750 $63,000
Q2 2023 Jul 21, 2023	BUY	$3.23 - $4.95 $9,690 - $14,850	3,000 Added 75.0%	7,000 $23,000
Q1 2023 Apr 18, 2023	BUY	$2.68 - $4.79 $10,720 - $19,160	4,000 New	4,000 $19,000
Q3 2021 Oct 27, 2021	SELL	$1.27 - $8.17 $127 - $817	-100 Closed	0 $0
Q2 2021 Sep 07, 2021	BUY	$6.55 - $8.98 $655 - $898	100 New	100 $1,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.